Taurine Ameliorates Impaired the Mitochondrial Function and Prevents Stroke-like Episodes in Patients with MELAS

Internal Medicine

Volumn 51, Issue 24, 2012, Pages 3351-3357

  Rikimaru, Mitsue ^a   Ohsawa, Yutaka ^a   Wolf, Alexander M ^b   Nishimaki, Kiyomi ^b   Ichimiya, Harumi ^b   Kamimura, Naomi ^b   Nishimatsu, Shin Ichiro ^a   Ohta, Shigeo ^b   Sunada, Yoshihide ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

MELAS; Post transcriptional modification; Stroke like episodes; Taurine

Indexed keywords

TAURINE;

ADULT; ARTICLE; CASE REPORT; CELL CULTURE; CEREBROVASCULAR ACCIDENT; DRUG EFFECT; FEMALE; HUMAN; MELAS SYNDROME; MITOCHONDRION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; CELLS, CULTURED; FEMALE; HUMANS; MELAS SYNDROME; MITOCHONDRIA; STROKE; TAURINE; YOUNG ADULT;

EID: 84877157309     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.7529     Document Type: Article

References (14)

1. Suzuki T, Nagao A, Suzuki T. Human mitochondrial diseases caused by lack of taurine modification in mitochondrial tRNAs. WIREs RNA 2: 376–386, 2011.
2. Click FHC. Codon-anticodon pairing: The wobble hypothesis. J Mol Biol 19: 548–555, 1966.
3. Curran JF. Modified nucleosides in translation. In: Modification and Editing of RNA. Grosjean H, Benne R, Eds. ASM Press, Washington, D.C, 1998: 493–516.
4. Yasukawa T, Suzuki T, Ishii N, Ueda T, Ohta S, Watanabe K. Defect in modification at the anticodon wobble nucleotide of mitochondrial tRNA (Lys) with the MERRF encephalomyopathy pathogenic mutation. FEBS Lett 467: 175–178, 2000.
5. Yasukawa T, Suzuki T, Ueda T, Ohta S, Watanabe K. Modification defect at anticodon wobble nucleotide of mitochondrial tRNAs (Leu) (UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. J Biol Chem 275: 4251–4257, 2000.
6. Yasukawa T, Suzuki T, Ishii N, Ohta S, Watanabe K. Wobble modification defect in tRNA disturbs codon-anticodon interaction in a mitochondrial disease. EMBO J 20: 4794–4802, 2001.
7. Suzuki T, Nagao A, Suzuki T. Human mitochondrial tRNAs: Biogenesis, function, structural aspects, and diseases. Annu Rev Genet 45: 299–329, 2011.
8. Kirino Y, Goto Y, Campos Y, et al. Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease. Proc Natl Acad Sci USA 102: 7127–7132, 2005.
9. Kirino Y, Yasukawa T, Ohta S, et al. Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease. Proc Natl Acad Sci USA 101: 15070–15075, 2004.
10. Hayashi J, Ohta S, Kikuchi A, et al. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci USA 88: 10614–10618, 1991.
11. Wolf AM, Asoh S, Hiranuma H, et al. Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress. J Nutr Biochem 21: 381–389, 2010.
12. Minamikawa T, Sriratana A, Williams DA, et al. Chloromethyl-X-rosamine (MitoTracker Red) photosensitizes mitochondria and induces apotosis in intact human cells. J Cell Sci 112: 2419–2430, 1999.
13. Kamada T, Koizumi T, Tsujii M, et al. Clinical evaluation by double-blind trial of taurine for acute hepatitis. Sulfur-containing Amino Acid 3: 223–235, 1980 (in Japanese).
14. Pion PD, Kittleson MD, Rogers QR, et al. Myocardial failure in cats associated with low plasma taurine: A reversible cardiomyopathy. Science 237: 764–768, 1987.